Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Humanwell Healthcare (600079)
- 18.80
- -0.18-0.95%
Trading Apr 17 13:58 CST
30.69BMarket Cap16.53P/E (TTM)
18.94High18.76Low79.22KlotVolume18.91Open18.98Prev Close149.04MTurnover0.51%Turnover Ratio16.53P/E (Static)1.63BShares23.6652wk High1.62P/B29.01BFloat Cap16.7352wk Low19.93Limit Up1.54BShs Float38.20Historical High18.03Limit Down0.95%Range %-1.05Historical Low0.32Dividend TTM18.81Avg Price54.11KlotAsk1.70%Div Yield TTM100Lot Size24.09KlotBid
Humanwell Healthcare (600079) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.79%23.96B | -6.58%17.88B | -6.20%12.06B | -3.61%6.14B | 3.71%25.44B | 5.70%19.14B | 3.86%12.86B | 2.28%6.37B | 9.79%24.52B | 11.42%18.11B |
| Operating revenue | -5.79%23.96B | -6.58%17.88B | -6.20%12.06B | -3.61%6.14B | 3.71%25.44B | 5.70%19.14B | 3.86%12.86B | 2.28%6.37B | 9.79%24.52B | 11.42%18.11B |
| Other operating revenue | -11.34%43.76M | ---- | -12.90%20.59M | ---- | -38.17%49.36M | ---- | -35.10%23.64M | ---- | 29.45%79.84M | ---- |
| Total operating cost | -8.92%20.64B | -8.19%15.28B | -7.45%10.3B | -4.43%5.34B | 5.83%22.67B | 5.90%16.64B | 4.25%11.13B | 2.80%5.58B | 7.88%21.42B | 10.49%15.72B |
| Operating cost | -12.01%12.41B | -8.67%9.31B | -8.67%6.25B | -7.49%3.16B | 6.11%14.1B | 3.94%10.19B | 1.61%6.84B | 2.33%3.41B | 5.36%13.29B | 6.61%9.81B |
| Operating tax surcharges | 32.39%236.06M | 7.14%172.45M | 11.07%115.83M | 5.11%53.8M | -7.01%178.31M | 29.18%160.96M | 7.30%104.29M | 3.30%51.19M | -6.86%191.75M | -8.21%124.6M |
| Operating expense | -3.51%4.47B | -5.34%3.29B | -7.04%2.21B | -3.23%1.16B | 5.29%4.63B | 3.46%3.48B | 0.81%2.38B | -5.40%1.2B | 2.88%4.4B | 9.09%3.36B |
| Administration expense | -10.66%1.73B | -10.67%1.24B | -8.90%852.54M | -0.27%485.19M | 9.18%1.93B | 15.00%1.39B | 29.24%935.87M | 32.30%486.5M | 14.03%1.77B | 16.06%1.21B |
| Financial expense | -13.56%303.15M | -35.04%212.61M | -22.02%120.84M | -16.80%66.93M | 15.17%350.7M | 54.61%327.27M | 37.59%154.96M | -33.93%80.45M | 28.52%304.52M | 64.54%211.68M |
| -Interest expense (Financial expense) | -22.86%271.04M | -20.54%214.48M | -13.29%154.94M | -5.03%80.92M | -0.78%351.37M | 0.84%269.92M | 3.02%178.69M | -9.59%85.2M | -25.69%354.14M | -31.47%267.66M |
| -Interest Income (Financial expense) | 48.96%-26.59M | 56.67%-17.4M | 38.33%-20.72M | 33.61%-9.09M | 11.35%-52.1M | -1.66%-40.15M | -80.92%-33.6M | -89.80%-13.69M | 58.97%-58.77M | 71.83%-39.49M |
| Research and development | 2.05%1.5B | -3.92%1.05B | 5.32%743.38M | 17.02%408.79M | 0.59%1.47B | 9.20%1.09B | 10.08%705.83M | 22.42%349.34M | 51.21%1.46B | 57.42%1B |
| Credit Impairment Loss | 74.56%-72.03M | 8.41%-44.7M | -14.70%-34.49M | 5.30%-15.98M | -92.17%-283.18M | 9.99%-48.8M | 37.19%-30.07M | 31.03%-16.88M | -263.56%-147.36M | -165.48%-54.21M |
| Asset Impairment Loss | -6.68%-420.17M | -328.19%-18.19M | -347.73%-18.07M | 34.81%1.33M | -541.39%-393.86M | 85.22%-4.25M | 86.18%-4.04M | 295.71%986.6K | 30.47%-61.41M | 28.06%-28.75M |
| Other net revenue | 51.35%-120.46M | -38.90%95.66M | -20.72%67.65M | 44.54%56.81M | -172.93%-247.59M | -54.98%156.56M | -71.22%85.33M | -81.93%39.3M | -67.04%339.49M | -68.70%347.74M |
| Fair value change income | -89.51%11.82M | 58.09%-3.04M | 71.41%-1.62M | 87.04%-847.38K | -17.64%112.72M | -106.98%-7.26M | -106.37%-5.66M | -107.21%-6.54M | 215.21%136.85M | 239.66%104.02M |
| Invest income | -24.08%101.04M | -26.20%59.39M | 64.99%47.37M | 57.16%26.51M | -35.64%133.09M | -58.97%80.48M | -84.73%28.71M | -84.20%16.87M | -75.25%206.79M | -78.65%196.14M |
| -Including: Investment income associates | 56.41%106.61M | 21.84%59.63M | 15.94%40.72M | 16.11%23.54M | 13.62%68.16M | 7.06%48.94M | -0.35%35.12M | -10.44%20.28M | 166.46%59.99M | -19.37%45.71M |
| Asset deal income | 1,342.59%55.57M | 83.53%-512.83K | 34.08%-351.25K | 258.62%1.84M | -312.20%-4.47M | -575.23%-3.11M | -1,504.44%-532.85K | 31.11%513.19K | 97.20%-1.08M | 118.07%655.1K |
| Other revenue | 8.07%203.31M | -26.37%102.71M | -22.81%74.81M | -0.88%43.96M | -8.54%188.13M | 7.40%139.5M | 0.31%96.92M | 0.88%44.35M | 9.36%205.7M | 6.08%129.88M |
| Operating profit | 26.80%3.2B | 1.62%2.7B | 0.79%1.83B | 4.23%857.3M | -26.84%2.52B | -3.19%2.66B | -9.27%1.82B | -18.67%822.51M | -1.96%3.45B | -12.72%2.74B |
| Add:Non operating Income | 19.62%11.2M | -26.15%4.79M | 211.31%3.94M | 112.16%1.33M | 13.03%9.36M | 359.69%6.48M | -35.04%1.27M | -72.11%627.7K | 52.18%8.28M | -77.35%1.41M |
| Less:Non operating expense | 40.57%152.6M | -1.79%71.9M | 7.06%49.23M | 129.09%31.19M | 51.56%108.56M | 95.93%73.21M | 192.02%45.98M | 30.57%13.62M | -24.93%71.63M | -42.67%37.37M |
| Total profit | 26.15%3.06B | 1.65%2.63B | 0.77%1.79B | 2.21%827.44M | -28.40%2.42B | -4.37%2.59B | -10.89%1.78B | -19.31%809.53M | -1.23%3.38B | -12.21%2.71B |
| Less:Income tax cost | -12.49%564M | -6.87%448.54M | -8.69%292.05M | -20.15%128.83M | 13.35%644.49M | 13.55%481.6M | 5.99%319.84M | 13.54%161.34M | 60.27%568.56M | 5.99%424.13M |
| Net profit | 40.16%2.49B | 3.59%2.18B | 2.85%1.5B | 7.78%698.62M | -36.83%1.78B | -7.70%2.11B | -13.90%1.46B | -24.73%648.19M | -8.34%2.82B | -14.93%2.28B |
| Net profit from continuing operation | 40.16%2.49B | 3.59%2.18B | 2.85%1.5B | 7.78%698.62M | -36.83%1.78B | -7.70%2.11B | -13.90%1.46B | -24.73%648.19M | -8.34%2.82B | -14.93%2.28B |
| Less:Minority Profit | 42.03%637.12M | -4.47%494.55M | -0.59%342.51M | -2.18%158.27M | -34.11%448.6M | 0.63%517.69M | -6.09%344.54M | -17.36%161.8M | 15.94%680.78M | 12.09%514.44M |
| Net profit of parent company owners | 39.53%1.86B | 6.22%1.69B | 3.92%1.15B | 11.09%540.35M | -37.70%1.33B | -10.12%1.59B | -16.07%1.11B | -26.89%486.39M | -14.07%2.13B | -20.50%1.77B |
| Earning per share | ||||||||||
| Basic earning per share | 39.02%1.14 | 5.10%1.03 | 4.41%0.71 | 10.00%0.33 | -37.88%0.82 | -10.09%0.98 | -17.07%0.68 | -26.83%0.3 | -14.29%1.32 | -21.01%1.09 |
| Diluted earning per share | 39.02%1.14 | 6.19%1.03 | 4.41%0.71 | 10.00%0.33 | -37.40%0.82 | -11.01%0.97 | -16.05%0.68 | -26.83%0.3 | -14.94%1.31 | -21.01%1.09 |
| Other composite income | -126.04%-34.52M | 7.40%130.81M | 165.56%87.57M | 23.07%-26.95M | 309.52%132.56M | 38.07%121.81M | -315.22%-133.56M | -2,311.99%-35.03M | -79.22%32.37M | -58.45%88.22M |
| Other composite income of parent company owners | -127.93%-41.45M | -6.53%122.89M | 163.12%78.87M | 4.58%-29.59M | 308.69%148.44M | 49.51%131.48M | -313.94%-124.96M | -2,398.18%-31.01M | -77.54%36.32M | -61.22%87.94M |
| Other composite income of minority owners | 143.66%6.93M | 181.86%7.92M | 201.09%8.7M | 165.81%2.64M | -301.94%-15.87M | -3,567.56%-9.68M | -335.71%-8.6M | -1,815.36%-4.02M | 33.25%-3.95M | 101.93%279.1K |
| Total composite income | 28.63%2.46B | 3.80%2.31B | 19.87%1.58B | 9.54%671.67M | -32.90%1.91B | -6.00%2.23B | -24.57%1.32B | -28.92%613.16M | -11.76%2.85B | -18.12%2.37B |
| Total composite income of parent company owners | 22.71%1.81B | 5.25%1.81B | 25.09%1.23B | 12.16%510.76M | -31.91%1.48B | -7.30%1.72B | -28.66%986.13M | -31.69%455.38M | -17.95%2.17B | -24.27%1.86B |
| Total composite income of minority owners | 48.84%644.05M | -1.09%502.47M | 4.55%351.2M | 1.99%160.91M | -36.07%432.72M | -1.30%508.01M | -9.34%335.93M | -19.51%157.78M | 16.44%676.83M | 15.79%514.72M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm